Press Release

Nuffield Health to enhance disease detection by cutting-edge imaging technology investment in PENTAX Medical

Nuffield Health to enhance disease detection by cutting-edge imaging technology investment in PENTAX Medical

December 3, 2012

 Nuffield Health has awarded a significant contract to PENTAX Medical for state-of-the-art imaging equipment to enhance its detection of diseases, such as cancer, and enable earlier treatment which can improve patient outcomes. As the UK’s largest health charity, Nuffield operates 31 hospitals nationwide, the majority of which will be re-equipped with the most advanced flexible endoscopes and imaging technology on the market in order to meet the accreditation of the Joint Advisory Group on GI Endoscopy (JAG). PENTAX Medical’s HD+ endoscopes incorporate the world’s first megapixel CCD to deliver exceptional high-definition images to better support clinicians in their diagnoses.

PENTAX Medical awarded significant contract for high definition HD+ endoscopes by UK’s largest health charity

 

David Moore (Managing Director, PENTAX Medical) with David Wylde (Regional Director – Hospitals, Nuffield Health)

 

David Moore (Managing Director, PENTAX Medical) with David Wylde (Regional Director – Hospitals, Nuffield Health)

 

PENTAX Medical has been providing some Nuffield hospitals with its extensive range of cutting-edge endoscopy equipment for a variety of procedures for over 15 years and is world-renowned for the quality, reliability, innovation and simplicity of its products. The new national contract offers exceptional value for money within flexible financial solutions, enabling increased investment by Nuffield Health in PENTAX Medical’s, high-definition endoscopes and associated technology. This will be backed up by PENTAX’s best in class service, support and training to wholly ensure that Nuffield’s patients are provided with the best possible care and clinical outcomes.

Use of PENTAX Medical’s revolutionary ‘i-scan’ imaging technology alongside the HD+ endoscope range will further improve imagery of tissues, such as those lining the stomach, intestines and bladder. Obtaining the best quality image possible inside a patient means disease can be detected earlier, before it reaches a serious stage, and treatment can begin without delay to improve a patient’s chance of recovery.

For example, colorectal cancer is one of the most common cancers worldwide, early detection of cancer, as well as detection and removal of polyps, using colonoscopy is vital to decrease disease mortality. Use of PENTAX HD+ colonoscopes in conjunction with i-scan has been shown to provide an enhanced resolution and visualisation of polyps1,2. This leads to a significantly higher detection rate of polyps, specifically potentially pre-cancerous tissues or adenomas, compared to standard video endoscopy during bowel cancer screening programmes.

Many leading doctors already trust PENTAX’s endoscopes to improve the detection and diagnosis of tissue abnormalities1,2,3. According to David Moore, Managing Director, PENTAX UK Ltd. “By choosing the most technologically advanced endoscopy products on the market that offer such exceptionally high image resolution, compared to standard endoscopes, Nuffield Health will be able to offer its patients significantly higher detection rates for cancers and other diseases, as well as enabling faster treatment turnaround times.”

David Wylde, Regional Director – Hospitals, Nuffield Health commented, “The new national contract with PENTAX Medical will ensure we can diagnose our patients using the most advanced endoscopy technology available within Nuffield Hospitals. We take pride in delivering an excellent service and being able to use the latest, cutting-edge technology means that we can deliver truly high class healthcare to our patients.

We are also extremely impressed with the expertise and knowledge held within the PENTAX Medical team who are evidently dedicated to delivering quality and excellence in both technology and after-sales care.  The introduction of PENTAX technology supports our upgrade of Endoscopy facilities to meet the accreditation of the Joint Advisory Group on GI Endoscopy (JAG) to ensure that we continue to be a provider of services of the highest quality.”

 

References:

  1. Banks M.R. et al. (2011). Comparison of PENTAX Hi Line and Olympus Lucera Colonoscopes for polyp detection in the UK bowel cancer screening programme. World Journal of Gastroenterology, 17 (38): 4308-4313.
  1. Hoffman A. et al. (2010). High definition colonoscopy combined with i-Scan is superior in the detection of colorectal neoplasias compared with standard video colonoscopy: a prospective randomized controlled trial. Endoscopy, 42(10):827-33.
  1. Endoscopy and Early Neoplasia: Embracing the Future. Gastroenterology Today (September 2012).

 

This Site Uses Cookies. This site uses some unobtrusive cookies to store information on your computer for technical/functional purposes. We also use some non-essential cookies to anonymously track visitors on our site/on third party sites or enhance your experience of the site. By using our site you accept these cookies. For more information please see our Cookie Policy